Global Artificial Blood Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch＇s in-depth investigation and research, the global Artificial Blood market size will reach 4,657.67 Million USD in 2025 and is projected to reach 10,290.19 Million USD by 2032, with a CAGR of 11.99% (2025-2032). Notably, the China Artificial Blood market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Artificial blood is a substance that mimics the oxygen-carrying properties of red blood cells. It is designed to replace or supplement the use of donated blood in transfusions, and can be used in emergency situations where donated blood is unavailable or in limited supply. Artificial blood is typically made using hemoglobin, the protein in red blood cells that carries oxygen, and can be either a standalone product or combined with other materials to form a blood substitute. While artificial blood research and development has been ongoing for several decades, no commercially available product has yet been widely adopted for human use.
The major global manufacturers of Artificial Blood include Dextro-Sang Corporation, BioPure Corporation, Sangart, Northfield Laboratories, Baxter International, Dentritech, FluorO2 Therapeutics, Nuvox Pharma, Alpha Therapeutic Corporation, HemoBioTech, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Artificial Blood. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Artificial Blood market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Artificial Blood market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Artificial Blood industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Artificial Blood Include:
Dextro-Sang Corporation
BioPure Corporation
Sangart
Northfield Laboratories
Baxter International
Dentritech
FluorO2 Therapeutics
Nuvox Pharma
Alpha Therapeutic Corporation
HemoBioTech
Artificial Blood Product Segment Include:
Human Blood
Synthetic Blood
Animal Blood
Artificial Blood Product Application Include:
Hemoglobin-Based Oxygen Carriers (HBOCs)
Perflurocarbon Emulsions (PFCEs)
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Artificial Blood Industry PESTEL Analysis
Chapter 3: Global Artificial Blood Industry Porter's Five Forces Analysis
Chapter 4: Global Artificial Blood Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Artificial Blood Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Artificial Blood Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Artificial Blood Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch＇s in-depth investigation and research, the global Artificial Blood market size will reach 4,657.67 Million USD in 2025 and is projected to reach 10,290.19 Million USD by 2032, with a CAGR of 11.99% (2025-2032). Notably, the China Artificial Blood market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Artificial blood is a substance that mimics the oxygen-carrying properties of red blood cells. It is designed to replace or supplement the use of donated blood in transfusions, and can be used in emergency situations where donated blood is unavailable or in limited supply. Artificial blood is typically made using hemoglobin, the protein in red blood cells that carries oxygen, and can be either a standalone product or combined with other materials to form a blood substitute. While artificial blood research and development has been ongoing for several decades, no commercially available product has yet been widely adopted for human use.
The major global manufacturers of Artificial Blood include Dextro-Sang Corporation, BioPure Corporation, Sangart, Northfield Laboratories, Baxter International, Dentritech, FluorO2 Therapeutics, Nuvox Pharma, Alpha Therapeutic Corporation, HemoBioTech, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Artificial Blood. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Artificial Blood market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Artificial Blood market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Artificial Blood industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Artificial Blood Include:
Dextro-Sang Corporation
BioPure Corporation
Sangart
Northfield Laboratories
Baxter International
Dentritech
FluorO2 Therapeutics
Nuvox Pharma
Alpha Therapeutic Corporation
HemoBioTech
Artificial Blood Product Segment Include:
Human Blood
Synthetic Blood
Animal Blood
Artificial Blood Product Application Include:
Hemoglobin-Based Oxygen Carriers (HBOCs)
Perflurocarbon Emulsions (PFCEs)
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Artificial Blood Industry PESTEL Analysis
Chapter 3: Global Artificial Blood Industry Porter's Five Forces Analysis
Chapter 4: Global Artificial Blood Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Artificial Blood Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Artificial Blood Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Artificial Blood Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Artificial Blood Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Artificial Blood Product by Type
- 1.2.1 Human Blood
- 1.2.2 Synthetic Blood
- 1.2.3 Animal Blood
- 1.3 Artificial Blood Product by Application
- 1.3.1 Hemoglobin-Based Oxygen Carriers (HBOCs)
- 1.3.2 Perflurocarbon Emulsions (PFCEs)
- 1.4 Global Artificial Blood Market Revenue and Sales Analysis
- 1.4.1 Global Artificial Blood Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Artificial Blood Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Artificial Blood Market Sales Price Trend Analysis (2020-2032)
- 1.5 Artificial Blood Market Development Status and Trends
- 1.5.1 Artificial Blood Industry Development Status Analysis
- 1.5.2 Artificial Blood Industry Development Trends Analysis
- 2 Artificial Blood Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Artificial Blood Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Artificial Blood Market Analysis by Country
- 4.1 Global Artificial Blood Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Artificial Blood Revenue and Market Share by Country (2020-2025)
- 4.1.2 Global Artificial Blood Revenue and Market Share Forecast by Country (2026-2032)
- 4.2 Global Artificial Blood Sales Analysis by Country: 2024 VS 2025 VS 2032
- 4.2.1 Global Artificial Blood Sales and Market Share by Country (2020-2025)
- 4.2.2 Global Artificial Blood Sales and Market Share Forecast by Country (2026-2032)
- 4.3 United States Artificial Blood Market Sales, Revenue and Growth Rate (2020-2032)
- 4.4 Germany Artificial Blood Market Sales, Revenue and Growth Rate (2020-2032)
- 4.5 Japan Artificial Blood Market Sales, Revenue and Growth Rate (2020-2032)
- 4.6 China Artificial Blood Market Sales, Revenue and Growth Rate (2020-2032)
- 4.7 France Artificial Blood Market Sales, Revenue and Growth Rate (2020-2032)
- 4.8 U.K. Artificial Blood Market Sales, Revenue and Growth Rate (2020-2032)
- 4.9 South Korea Artificial Blood Market Sales, Revenue and Growth Rate (2020-2032)
- 4.10 Canada Artificial Blood Market Sales, Revenue and Growth Rate (2020-2032)
- 4.11 Italy Artificial Blood Market Sales, Revenue and Growth Rate (2020-2032)
- 4.12 Russia Artificial Blood Market Sales, Revenue and Growth Rate (2020-2032)
- 4.13 Mexico Artificial Blood Market Sales, Revenue and Growth Rate (2020-2032)
- 4.14 Brazil Artificial Blood Market Sales, Revenue and Growth Rate (2020-2032)
- 4.15 India Artificial Blood Market Sales, Revenue and Growth Rate (2020-2032)
- 4.16 Vietnam Artificial Blood Market Sales, Revenue and Growth Rate (2020-2032)
- 4.17 Thailand Artificial Blood Market Sales, Revenue and Growth Rate (2020-2032)
- 4.18 South Africa Artificial Blood Market Sales, Revenue and Growth Rate (2020-2032)
- 5 Competition by Manufacturers
- 5.1 Global Artificial Blood Market Sales, Revenue and Sales Price by Key Manufacturers (2021-2025)
- 5.1.1 Global Artificial Blood Market Sales by Key Manufacturers (2021-2025)
- 5.1.2 Global Artificial Blood Market Revenue by Key Manufacturers (2021-2025)
- 5.1.3 Global Artificial Blood Average Sales Price by Manufacturers (2021-2025)
- 5.2 Artificial Blood Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Artificial Blood Competitive Landscape Analysis
- 5.2.2 Global Key Manufacturers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Artificial Blood Market Analysis by Type
- 6.1 Global Artificial Blood Market Revenue Analysis by Type
- 6.1.1 Global Artificial Blood Market Size Analysis by Type: 2024 & 2025 & 2032
- 6.1.2 Global Artificial Blood Revenue and Forecast Analysis by Type (2020-2032)
- 6.2 Global Artificial Blood Market Sales and Forecast Analysis by Type (2020-2032)
- 6.3 Global Artificial Blood Sales Price Trend Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Dextro-Sang Corporation
- 7.1.1 Dextro-Sang Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Dextro-Sang Corporation Artificial Blood Product Portfolio
- 7.1.3 Dextro-Sang Corporation Artificial Blood Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.2 BioPure Corporation
- 7.2.1 BioPure Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 BioPure Corporation Artificial Blood Product Portfolio
- 7.2.3 BioPure Corporation Artificial Blood Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.3 Sangart
- 7.3.1 Sangart Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Sangart Artificial Blood Product Portfolio
- 7.3.3 Sangart Artificial Blood Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.4 Northfield Laboratories
- 7.4.1 Northfield Laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Northfield Laboratories Artificial Blood Product Portfolio
- 7.4.3 Northfield Laboratories Artificial Blood Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.5 Baxter International
- 7.5.1 Baxter International Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Baxter International Artificial Blood Product Portfolio
- 7.5.3 Baxter International Artificial Blood Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.6 Dentritech
- 7.6.1 Dentritech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Dentritech Artificial Blood Product Portfolio
- 7.6.3 Dentritech Artificial Blood Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.7 FluorO2 Therapeutics
- 7.7.1 FluorO2 Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 FluorO2 Therapeutics Artificial Blood Product Portfolio
- 7.7.3 FluorO2 Therapeutics Artificial Blood Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.8 Nuvox Pharma
- 7.8.1 Nuvox Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Nuvox Pharma Artificial Blood Product Portfolio
- 7.8.3 Nuvox Pharma Artificial Blood Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.9 Alpha Therapeutic Corporation
- 7.9.1 Alpha Therapeutic Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Alpha Therapeutic Corporation Artificial Blood Product Portfolio
- 7.9.3 Alpha Therapeutic Corporation Artificial Blood Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.10 HemoBioTech
- 7.10.1 HemoBioTech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 HemoBioTech Artificial Blood Product Portfolio
- 7.10.3 HemoBioTech Artificial Blood Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
